Spinal intramedullary uterine carcinosarcoma metastasis.
Waldo SolisAndrew M YoussefRichard ShawYingda LiPublished in: BMJ case reports (2024)
Intramedullary spinal cord metastases (ISCM) are a rare and challenging manifestation of metastatic cancer that have devastating impacts on the individual's neurological function, survival expectancy and overall quality of life. Given the rarity and poor prognosis, there is a lack of consensus in management. Uterine carcinosarcoma itself is a rare cancer, accounting for less than 3% of all uterine cancers. It carries a poor prognosis, with only one-third of patients surviving beyond 5 years. There are no previous reports of uterine carcinosarcoma metastases to the spinal cord. Here, we present the case of a woman in her late 70s with a uterine carcinosarcoma intramedullary metastasis that was refractory to radiotherapy treatment and responded favourably to surgical debulking.
Keyphrases
- poor prognosis
- spinal cord
- long non coding rna
- papillary thyroid
- end stage renal disease
- spinal cord injury
- squamous cell carcinoma
- ejection fraction
- newly diagnosed
- small cell lung cancer
- squamous cell
- chronic kidney disease
- emergency department
- locally advanced
- peritoneal dialysis
- prognostic factors
- radiation therapy
- case report
- patient reported
- lymph node
- childhood cancer
- lymph node metastasis
- rectal cancer
- free survival